Report an error

Spotted something inaccurate in “LIG1 Loss Marks TNBC Tumors Vulnerable to Olaparib-Ceralasertib Combination”? Tell us what’s wrong and we’ll check it against the original source.

Website

Send report Cancel

This form is for factual corrections. We read every report but cannot reply individually.